Want to see FR:ALTME full AI Analyst Report?
TME Pharma N.V. (ALTME) Income Statement
5 Followers
TME Pharma N.V. Income Statement
Last quarter (Q2 2026), TME Pharma N.V.'s total revenue was €0.00. In Q2, TME Pharma N.V.'s net income was €-507.00K. See TME Pharma N.V.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| € 0.00 | € 19.00K | € 17.00K | € 0.00 | € 33.00K | |
| € -8.00K | € -78.00K | € -127.00K | € -92.00K | € -65.97K | |
| € 2.90M | € 5.20M | € 5.50M | € 12.00M | € 13.45M | |
| Depreciation and Amortization | € 8.00K | € 78.00K | € 144.00K | € 92.00K | € 66.00K |
| € -2.90M | € -5.17M | € -5.07M | € -11.63M | € -12.88M | |
| € -2.91M | € -5.28M | € -5.62M | € -12.03M | € -13.27M | |
| € -377.00K | € -445.00K | € -1.11M | € -3.10M | € -1.19M | |
| € -3.29M | € -5.72M | € -6.73M | € -15.13M | € -14.45M | |
| € -3.29M | € -5.72M | € -6.74M | € -15.13M | € -14.45M | |
| Per Share Metrics | |||||
| Basic EPS | € -0.03 | € -0.21 | € -1.34 | € -12.86 | € -21.90 |
| Diluted EPS | € -0.03 | € -0.21 | € -1.34 | € -12.86 | € -21.90 |
| Weighted Average Shares Outstanding | 94.15M | 27.35M | 5.02M | 1.18M | 659.00K |
| Weighted Average Shares Outstanding (Diluted) | 94.15M | 27.35M | 5.02M | 1.18M | 659.85K |
Currency in EUR
